366 related articles for article (PubMed ID: 25671592)
1. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
Reddy SV; Reddy KT; Kumari VV; Basha SH
J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
[TBL] [Abstract][Full Text] [Related]
2. Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1.
Jiang S; Li H; Piao L; Jin Z; Liu J; Chen S; Liu LL; Shao Y; Zhong S; Wu B; Li W; Ren J; Zhang Y; Wang H; Jin R
Aging (Albany NY); 2020 Jun; 12(12):11349-11363. PubMed ID: 32568737
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
4. Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study.
Cai Z; Zhang G; Tang B; Liu Y; Fu X; Zhang X
Cell Biochem Biophys; 2015 Jul; 72(3):727-39. PubMed ID: 25627548
[TBL] [Abstract][Full Text] [Related]
5. In Silico Elucidation of the Plausible Inhibitory Potential of Withaferin A of Withania Somnifera Medicinal Herb Against Breast Cancer Targeting Estrogen Receptor.
Ali MA; Farah MA; Al-Anazi KM; Basha SH; Bai F; Lee J; Al-Hemaid FMA; Mahmoud AH; Hailan WAQ
Curr Pharm Biotechnol; 2020; 21(9):842-851. PubMed ID: 31995002
[TBL] [Abstract][Full Text] [Related]
6. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
[TBL] [Abstract][Full Text] [Related]
7. Research progress of indoleamine 2,3-dioxygenase inhibitors.
Jiang T; Sun Y; Yin Z; Feng S; Sun L; Li Z
Future Med Chem; 2015; 7(2):185-201. PubMed ID: 25686005
[TBL] [Abstract][Full Text] [Related]
8. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
[TBL] [Abstract][Full Text] [Related]
9. Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO).
Macchiarulo A; Nuti R; Bellocchi D; Camaioni E; Pellicciari R
Biochim Biophys Acta; 2007 Aug; 1774(8):1058-68. PubMed ID: 17644054
[TBL] [Abstract][Full Text] [Related]
10. Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase.
Capece L; Arrar M; Roitberg AE; Yeh SR; Marti MA; Estrin DA
Proteins; 2010 Nov; 78(14):2961-72. PubMed ID: 20715188
[TBL] [Abstract][Full Text] [Related]
11. Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
Dolušić E; Larrieu P; Blanc S; Sapunaric F; Pouyez J; Moineaux L; Colette D; Stroobant V; Pilotte L; Colau D; Ferain T; Fraser G; Galleni M; Frère JM; Masereel B; Van den Eynde B; Wouters J; Frédérick R
Eur J Med Chem; 2011 Jul; 46(7):3058-65. PubMed ID: 21419531
[TBL] [Abstract][Full Text] [Related]
12. Marine natural products and other derivatives as potent indoleamine 2,3-dioxygenase inhibitors.
Delfourne E
Mini Rev Med Chem; 2012 Sep; 12(10):988-96. PubMed ID: 22512584
[TBL] [Abstract][Full Text] [Related]
13. Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A.
Vadloori B; Sharath AK; Prabhu NP; Maurya R
BMC Res Notes; 2018 Apr; 11(1):246. PubMed ID: 29661206
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase, an emerging target for anti-cancer therapy.
Liu X; Newton RC; Friedman SM; Scherle PA
Curr Cancer Drug Targets; 2009 Dec; 9(8):938-52. PubMed ID: 20025603
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors.
Muller AJ; Malachowski WP; Prendergast GC
Expert Opin Ther Targets; 2005 Aug; 9(4):831-49. PubMed ID: 16083346
[TBL] [Abstract][Full Text] [Related]
16. Biochemical properties of indoleamine 2,3-dioxygenase: from structure to optimized design of inhibitors.
Lancellotti S; Novarese L; De Cristofaro R
Curr Med Chem; 2011; 18(15):2205-14. PubMed ID: 21517759
[TBL] [Abstract][Full Text] [Related]
17. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy. Laboratory investigation.
Miyazaki T; Moritake K; Yamada K; Hara N; Osago H; Shibata T; Akiyama Y; Tsuchiya M
J Neurosurg; 2009 Aug; 111(2):230-7. PubMed ID: 19199463
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate.
Crosignani S; Bingham P; Bottemanne P; Cannelle H; Cauwenberghs S; Cordonnier M; Dalvie D; Deroose F; Feng JL; Gomes B; Greasley S; Kaiser SE; Kraus M; Négrerie M; Maegley K; Miller N; Murray BW; Schneider M; Soloweij J; Stewart AE; Tumang J; Torti VR; Van Den Eynde B; Wythes M
J Med Chem; 2017 Dec; 60(23):9617-9629. PubMed ID: 29111717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
